Wilms' tumorigenesis is altered by misexpression of the transcriptional co-activator, CITED1

Journal of Pediatric Surgery

Volumn 42, Issue 3, 2007, Pages 474-481

  Lovvorn III, Harold N ^a   Boyle, Scott ^a   Shi, Genbin ^a   Shyr, Yu ^a   Wills, Marcia L ^a   Perantoni, Alan O ^b   de Caestecker, Mark ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

CITED1; Melanocyte specific gene 1; Mesenchymal to epithelial conversion; Wilms' tumor

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR; CITED1 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; NEPHROBLASTOMA; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR VOLUME;

ANIMALS; CELL LINE, TUMOR; GENE TRANSFER TECHNIQUES; HUMANS; MICE; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; WILMS TUMOR;

EID: 33847308053     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2006.10.054     Document Type: Article

References (33)

1. Green D.M., D'Angio G.J., Beckwith J.B., et al. Wilms' tumor. Cancer J Clin 46 (1996) 46-63
2. Breslow N., Olshan A., Beckwith J.B., et al. Epidemiology of Wilms' tumor. Med Pediatr Oncol 21 (1993) 172-181
3. Birch J.M., and Breslow N. Epidemiologic features of Wilms' tumor. Hematol Oncol Clin 9 (1995) 1157-1175
4. Beckwith J.B. The impact of tumor histology on treatment and prognosis of pediatric neoplasms. Semin Pediatr Surg 2 (1993) 11-18
5. Beckwith J.B. New developments in the pathology of Wilms' tumor. Cancer Invest 15 (1997) 153-162
6. Coppes M.J. The management and biological behavior of Wilms' tumor. Int Rev Exp Pathol 35 (1994) 150-176
7. Beckwith J.B., Zuppan C.E., Browning N.G., et al. Histological analysis of aggressiveness and responsiveness in Wilms' tumor. Med Pediatr Oncol 27 (1996) 422-428
8. Schmidt D., and Beckwith J.B. Histopathology of childhood renal tumors. Hematol Oncol Clin 9 (1995) 1179-1200
9. Shioda T., Fenner M.H., and Isselbacher K.J. MSG1, a novel melanocyte-specific gene, encodes a nuclear protein and is associated with pigmentation. Proc Natl Acad Sci U S A 93 (1996) 12298-12303
10. Dunwoodie S.L., Rodriguez T.A., and Beddington R.S. Msg1 and Mrg1, founding members of a gene family, show distinct patterns of gene expression during mouse embryogenesis. Mech Dev 72 (1998) 27-40
11. Plisov S., Tsang M., Shi G., et al. Cited1 is a bifunctional transcriptional cofactor that regulates early nephronic patterning. J Am Soc Nephrol 16 (2005) 1632-1644
12. Shioda T., Fenner M.H., and Isselbacher K.J. MSG1 and its related protein MRG1 share a transcription activating domain. Gene 204 (1997) 235-241
13. Yahata T., de Caestecker M.P., Lechleider R.J., et al. The MSG1 non-DNA-binding transactivator binds to the p300/CBP co-activators, enhancing their functional link to the Smad transcription factors. J Biol Chem 275 12 (2000) 8825-8834
14. Yahata T., Shao W., Endoh H., et al. Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein. Genes Dev 15 (2001) 2598-2612
15. Shioda T., Lechleider R.J., Dunwoodie S.L., et al. Transcriptional activating activity of Smad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivator. Proc Natl Acad Sci U S A 95 (1998) 9785-9790
16. de Caestecker M.P., Yahata T., Wang D., et al. The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain. J Biol Chem 275 3 (2000) 2115-2122
17. Li H., Ahmed N.U., Fenner M.H., et al. Regulation of expression of MSG1 melanocyte-specific nuclear protein in human melanocytes and melanoma cells. Exp Cell Res 242 (1998) 478-486
18. Lorens J.B., Bennett M.K., Pearsall D.M., et al. Retroviral delivery of peptide modulators of cellular functions. Mol Ther 1 (2000) 438-447
19. Lovvorn H.N., Savani R.C., Ruchelli E., et al. Serum hyaluronan and its association with unfavorable histology and aggressiveness of heterotransplanted Wilms' tumor. J Pediatr Surg 35 (2000) 1070-1078
20. Muller N., Reinacher-Schick A., Baldus S., et al. Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells. Oncogene 21 (2002) 6049-6058
21. Duda D.G., Sunamura M., Lefter L.P., et al. Restoration of Smad4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells. Oncogene 22 (2003) 6857-6864
22. Jazag A., Ijichi H., Kanai F., et al. Smad4 silencing in pancreatic cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-β. Oncogene 24 (2005) 662-671
23. Tang Y., Katuri V., Srinivasan R., et al. Transforming growth factor-β suppresses nonmetastatic colon cancer through Smad4 and adaptor protein ELF at an early stage of tumorigenesis. Cancer Res 65 10 (2005) 4228-4237
24. Knudson A.G. Mutation and cancer: statistical study of retinoblastoma. Proc Nat Acad Sci U S A 68 4 (1971) 820-823
25. Knudson A.G., and Strong L.C. Mutation and cancer: a model for Wilms' tumor of the kidney. J Natl Cancer Inst 48 (1972) 313-324
26. Oxburgh L., Chu G.C., Michael S.K., et al. TGF-beta superfamily signals are required for morphogenesis of the kidney mesenchyme progenitor population. Development 131 (2004) 4593-4605
27. Stark K., Vainio S., Vassileva G., and McMahon A.P. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372 (1994) 679-683
28. Dudley A.T., Lyons K.M., and Robertson E.J. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9 (1995) 2795-2807
29. Dudley A.T., Godin R.E., and Robertson E.J. Interaction between FGF and BMP signaling pathways regulates development of metanephric mesenchyme. Genes Dev 13 (1999) 1601-1613
30. Heldin C.H., Miyazono K., and ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390 (1997) 465-471
31. Macias-Silva M., Hoodless P.A., Tang S.J., et al. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J Biol Chem 273 (1998) 25628-25636
32. Luo G., Hofmann C., Bronckers A.L., et al. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 9 (1995) 2808-2820
33. Plisov S.Y., Yoshino K., Dove L.F., et al. TGFb2, LIF and FGF2 cooperate to induce nephrogenesis. Development 128 (2001) 1045-1057